Citation Impact
Citing Papers
Risk Factors for Lymphedema after Breast Cancer Treatment
2010
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer
2008 Standout
Breast cancer
2019 Standout
Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients
2003
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
2021
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
2012 Standout
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Impairments, Activity limitations and participation restrictions 6 and 12 months after breast cancer operation
2004
Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study
2013 Standout
Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy
2008
A comparative analysis of radiotherapy use and patient outcome in males and females with breast cancer
2005
Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases
2010 Standout
Decision aids for breast and nodal surgery in patients with early breast cancer: Development and a pilot study
2011
Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer
2005
Breast cancer
2016 Standout
The Risk of Developing Arm Lymphedema Among Breast Cancer Survivors: A Meta-Analysis of Treatment Factors
2009
Rehabilitation in Women with Breast Cancer
2007
Carcinoma of the breast in males
1998
Shoulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection – data from a prospective randomised trial
2008
Incidence and Time Path of Lymphedema in Sentinel Node Negative Breast Cancer Patients: A Systematic Review
2015
Sentinel lymph node biopsy in breast cancer
2002
A Novel Imaging System Permits Real-time in Vivo Tumor Bed Assessment After Resection of Naturally Occurring Sarcomas in Dogs
2012
TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab
2011
Axillary Recurrence Rate After Negative Sentinel Node Biopsy in Breast Cancer
2008
Stages at presentation, prognostic factors, and outcome of breast cancer in males
1999
Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial
2006 Standout
Morbidity of Sentinel Node Biopsy in Breast Cancer: The Relationship Between the Number of Excised Lymph Nodes and Lymphedema
2010
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
2011 Standout
Li-Fraumeni syndrome – a molecular and clinical review
1997
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006
2007
Obesity is a Risk Factor for Developing Postoperative Lymphedema in Breast Cancer Patients
2009
The post ACOSOG Z0011 era: Does our new understanding of breast cancer really change clinical practice?
2012
Update on Prevalence of Pain in Patients With Cancer: Systematic Review and Meta-Analysis
2016 Standout
Breast carcinoma in men
2004 Standout
Clinical relevance of biologic factors in male breast cancer
2001
Morbidity after axillary sentinel lymph node biopsy in patients with cutaneous melanoma
2005
Breast cancer related lymphedema in patients with different loco-regional treatments
2012
Male breast carcinoma
1999
The landscape of long noncoding RNAs in the human transcriptome
2015 Standout
Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping
2003 StandoutNobel
Intensified Neoadjuvant Chemotherapy in Early-Responding Breast Cancer: Phase III Randomized GeparTrio Study
2008
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: A systematic review
2009
Validation of a Nomogram to Predict the Risk of Nonsentinel Lymph Node Metastases in Breast Cancer Patients with a Positive Sentinel Node Biopsy: Validation of the MSKCC Breast Nomogram
2009
Deep learning in histopathology: the path to the clinic
2021 Standout
Male breast cancer
2006 Standout
Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases
2009
Return-to-work interventions integrated into cancer care: a systematic review
2010 Standout
Imaging Primary Mouse Sarcomas After Radiation Therapy Using Cathepsin-Activatable Fluorescent Imaging Agents
2013 StandoutNobel
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
Morbidity of Sentinel Node Biopsy: Relationship Between Number of Excised Lymph Nodes and Patient Perceptions of Lymphedema
2011
Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis
2011 Standout
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
Surgical Complications Associated With Sentinel Lymph Node Biopsy: Results From a Prospective International Cooperative Group Trial
2006
One-year morbidity after sentinel node biopsy and breast surgery
2005
Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis
2013 Standout
Sentinel node identification rate, but not accuracy, is significantly decreased after pre-operative chemotherapy in axillary node-positive breast cancer patients
2006
A prospective study of adjuvant CMF in males with node positive breast cancer: 20-year follow-up
2006
Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer
2013 Standout
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Repertoire Enhancement with Adoptively Transferred Female Lymphocytes Controls the Growth of Pre-Implanted Murine Prostate Cancer
2012 StandoutNobel
Upper‐body morbidity after breast cancer
2012
Longitudinal change of treatment‐related upper limb dysfunction and its impact on late dysfunction in breast cancer survivors: A prospective cohort study
2009
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial
2010 Standout
Lymphedema beyond breast cancer
2010 Standout
Breast Cancer
2009
Ductal carcinoma in situ (DCIS) in the male breast
1998
The consequences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance
2005
Male breast cancer
2009
Comprehensive Axillary Evaluation in Neoadjuvant Chemotherapy Patients With Ultrasonography and Sentinel Lymph Node Biopsy
2005
Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: A systematic review and meta-analysis of the literature
2008
Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy
2003
19. MALE BREAST CANCER: AETIOLOGY, GENETICS AND CLINICAL MANAGEMENT
2002
Prevalence of Lymphedema in Women With Breast Cancer 5 Years After Sentinel Lymph Node Biopsy or Axillary Dissection: Objective Measurements
2008
Trastuzumab in the management of early and advanced stage breast cancer.
2007
American College of Sports Medicine Roundtable on Exercise Guidelines for Cancer Survivors
2010 Standout
Apoptosis: A Review of Programmed Cell Death
2007 Standout
Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Breast Cancer: Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27
2005
Breast Cancer Statistics, 2022
2022 Standout
Correlation Between Clinical Nodal Status and Sentinel Lymph Node Biopsy False Negative Rate After Neoadjuvant Chemotherapy
2012
An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients
1999
Revision of the American Joint Committee on Cancer Staging System for Breast Cancer
2002
Simultaneous Immunohistochemical Detection of Tumor Cells in Lymph Nodes and Bone Marrow Aspirates in Breast Cancer and Its Correlation With Other Prognostic Factors
2001
American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer
2005 Standout
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer
2005
Decision aids for people facing health treatment or screening decisions
2017 Standout
Prognostic Variables in Male Breast Cancer
2000
Lymphedema and Quality of Life in Breast Cancer Survivors: The Iowa Women's Health Study
2008
Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
2014
Cancer treatment and survivorship statistics, 2016
2016 Standout
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy for Advanced Breast Cancer: Results of Ganglion Sentinelle et Chimiothérapie Neoadjuvante, a French Prospective Multicentric Study
2008
Sentinel Node Biopsy: Interpretation and Management of Patients With Immunohistochemistry-Positive Sentinel Nodes and Those With Micrometastases
2008
Strategies in treating male breast cancer
2007
Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis
2017 Standout
Male Breast Cancer: A Population-Based Comparison With Female Breast Cancer
2009 Standout
Prevalence of Lymphedema in Women With Breast Cancer 5 Years After Sentinel Lymph Node Biopsy or Axillary Dissection: Patient Perceptions and Precautionary Behaviors
2008
Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy
2007 Standout
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Feasibility and Accuracy of Sentinel Lymph Node Biopsy After Preoperative Chemotherapy in Breast Cancer Patients With Documented Axillary Metastases
2007
Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations
2010 Standout
Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis
2006 Standout
Recent progress in the treatment and prevention of cancer‐related lymphedema
2014
Lymphedema in Breast Cancer Survivors: Incidence, Degree, Time Course, Treatment, and Symptoms
2008
Post-mastectomy radiation in male breast cancer
2002
Morbidity After Sentinel Lymph Node Biopsy in Primary Breast Cancer: Results From a Randomized Controlled Trial
2005
Phase II Trial of Neoadjuvant Nab-Paclitaxel in High Risk Patients With Prostate Cancer Undergoing Radical Prostatectomy
2009
Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers
2011
Prevalence of upper-body symptoms following breast cancer and its relationship with upper-body function and lymphedema.
2010
Breast Cancer in Men
2002 Standout
Primary Systemic Therapy of Breast Cancer
2006
Works of A. Haid being referenced
Medium-term follow-up data after sentinel node biopsy alone for breast cancer
2006
Shoulder–arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer
2002
A nonrandomized follow-up comparison between standard axillary node dissection and sentinel node biopsy in breast cancer
2007
Invasive ductal carcinoma and invasive lobular carcinoma of breast differ in response following neoadjuvant therapy with epidoxorubicin and docetaxel + G-CSF
2006
Präoperative Axillasonographie beim Mammakarzinom: Wertigkeit der Methode im Routinebetrieb
2008
Klinische Wertigkeit und zuk�nftige Aspekte der "Sentinel Node Biopsy" beim Mammakarzinom
2003
A constitutional de novo mutation in exon 8 of the p53 gene in a patient with multiple primary malignancies
1996
Sentinel Lymph Node Biopsy After Preoperative Chemotherapy for Breast Cancer: Findings from the Austrian Sentinel Node Study Group
2008
Adjuvant extension of chemotherapy after neoadjuvant therapy may not improve outcome in early-stage breast cancer
2008
Morbidity of Breast Cancer Patients Following Complete Axillary Dissection or Sentinel Node Biopsy Only: A Comparative Evaluation
2002
Intra-operative Sonography: A Valuable Aid During Breast-Conserving Surgery for Occult Breast Cancer
2007
[Sentinel node biopsy in breast cancer--a minimally invasive procedure for staging of the axilla].
1999
Male breast cancer: Austrian experience
1995
Is sentinel lymph node biopsy reliable and indicated after preoperative chemotherapy in patients with breast carcinoma?
2001
Prediction of non-sentinel lymph node status in breast cancer with a micrometastatic sentinel node
2005
Pathologic Complete Response With Six Compared With Three Cycles of Neoadjuvant Epirubicin Plus Docetaxel and Granulocyte Colony-Stimulating Factor in Operable Breast Cancer: Results of ABCSG-14
2007
Multicentric Breast Cancer: A New Indication for Sentinel Node Biopsy—A Multi-Institutional Validation Study
2006